Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment - Response Journal Article


Authors: Glezerman, I. G.; Hu, M. I.; Jain, R. K.
Article Title: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment - Response
Keywords: bone neoplasms; drug efficacy; drug safety; bone metastasis; outcome assessment; letter; calcium; calcium blood level; hypercalcemia; diphosphonates; bone density conservation agents; hypocalcemia; denosumab; antibodies, monoclonal, humanized; osteoclastoma; humans; human; male; female; priority journal; severe renal impairment
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 106
Issue: 7
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2014-07-09
Start Page: dju138
Language: English
DOI: 10.1093/jnci/dju138
PUBMED: 24906399
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 2 September 2014 -- CODEN: JNCIA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors